Polynovo (PNV) is held by 5 ASX ETFs as of 15 Oct 2026. It weighs most in SSO, at 0.2% of the fund. Over the last year it fell 36.3%: on $10,000, −$3630. We explain 6 big moves in that time.
About PNV
- SectorHealth Care
- IndustryHealth Care Equipment & Services
- Size$625.2m
- Held by5 ETFs
- Big moves6 in 1Y
Each dot is a move we explain. Tap one, or a row of Why it moved, to see what caused it.
Why it moved
- +2.5%peak +16.4%27 Aug 2026· Earnings Beat
PolyNovo shares rebounded after investors digested the FY26 results webinar recording released the prior day, with the market reassessing the initial negative reaction to the results presentation.
- −5.2%peak −12.1%26 Aug 2026· Stake Change
A substantial holder ceased their position in PolyNovo, signalling a large institutional seller exiting the stock and triggering a sell-off.
- −2.6%peak −7.4%23 Jul 2026· Earnings Miss
PolyNovo's FY26 trading update disappointed investors despite reporting $150M in annual group revenue, triggering a sell-off as the market judged the result or outlook as below expectations.
- +11.9%25 May 2026· Unknown
No specific company news was found to explain the price move.
- +14.9%15 May 2026· Unknown
Insufficient news coverage to explain the 14.85% stock rise.
- −8.5%20 Feb 2026· Unknown
PolyNovo shares fell 8.46% despite a positive earnings report, likely due to profit-taking after the price rise or disappointment with the sales growth pace relative to expectations.
Held by 5 ETFs
Of every $10,000 in each fund, how much is in PNV today.
Other Health Care companies
- SHLSonic Healthcare47 ETFs
- RMDResMed44 ETFs
- CSLCSL Limited42 ETFs
- BDXBcal36 ETFs
- CSXCleanspace36 ETFs
- REGRegis Health33 ETFs
- TLXTelix Pharma32 ETFs
- SIGSigma Healthcare31 ETFs
Why did PNV fall 9.6% on 14 May 2025?
Polynovo
Polynovo's shares likely fell due to profit-taking after a sharp surge on positive diabetes breakthrough news the previous day.
The news on 13 May indicates a significant share price rise following positive results for NovoSorb BTM in diabetes, while the price move on 14 May is down. This pattern suggests a classic 'buy the rumor, sell the news' reaction or profit-taking after the strong prior-day gain. No negative operational news is present around the event date, and the stock's known short interest makes a short squeeze-induced reversal also plausible but unconfirmed.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice. It does not consider your objectives, finances or needs. Past performance is not a guide to future performance.
Evidence
News coverage
What it did to the 5 ETFs holding PNV
On $10,000 in each fund, at the weight it holds today